1. Home
  2. DDS vs TGTX Comparison

DDS vs TGTX Comparison

Compare DDS & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$628.96

Market Cap

8.2B

ML Signal

HOLD

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$54.55

Market Cap

7.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
TGTX
Founded
1938
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.9B
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
DDS
TGTX
Price
$628.96
$54.55
Analyst Decision
Sell
Strong Buy
Analyst Count
3
5
Target Price
$519.67
$49.80
AVG Volume (30 Days)
145.8K
1.8M
Earning Date
05-14-2026
05-04-2026
Dividend Yield
5.55%
N/A
EPS Growth
N/A
1746.67
EPS
22.30
0.17
Revenue
$6,563,336,000.00
$2,785,000.00
Revenue This Year
$0.99
$49.08
Revenue Next Year
$1.09
$26.69
P/E Ratio
$28.93
$326.94
Revenue Growth
N/A
N/A
52 Week Low
$503.06
$26.76
52 Week High
$741.98
$59.30

Technical Indicators

Market Signals
Indicator
DDS
TGTX
Relative Strength Index (RSI) 53.00 53.05
Support Level $604.78 $51.51
Resistance Level $642.51 $58.04
Average True Range (ATR) 21.43 2.79
MACD -0.03 0.16
Stochastic Oscillator 50.95 54.76

Price Performance

Historical Comparison
DDS
TGTX

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. It operates Dillard's stores, clearance centers, and an Internet store at dillards.com, offering a wide selection of merchandise, including fashion apparel for women, men, and children, accessories, cosmetics, home furnishings, and other consumer goods. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company also operates a general contracting construction company, which is involved in constructing and remodelling stores for Dillard's. It operates in two business segments: Retail Operations, which generates the maximum revenue, and Construction.

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

Share on Social Networks: